Fny Investment Advisers, LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Fny Investment Advisers, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Jan 10, 2020	SELL	$36.21 - $51.4 $108 - $154	-3 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	$22.22 - $44.01 $199 - $396	-9 Reduced 75.0%	3 $0
Q1 2019 Apr 17, 2019	SELL	$16.17 - $27.38 $80 - $136	-5 Reduced 29.41%	12 $0
Q4 2018 Jan 22, 2019	BUY	$14.32 - $22.92 $200 - $320	14 Added 466.67%	17 $0
Q3 2018 Nov 07, 2018	SELL	$13.03 - $21.81 $182 - $305	-14 Reduced 82.35%	3 $0
Q3 2018 Oct 29, 2018	BUY	$13.03 - $21.81 $78 - $130	6 Added 54.55%	17 $0
Q2 2018 Jul 18, 2018	BUY	$15.07 - $22.34 $165 - $245	11 New	11 $0

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.